CORRECTION OF LIPID EXCHANGE DEVIATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASES WITH CONCOMINANT DIABETES MELLITUS

Authors

  • O. S. Khukhlina ВДНЗ України «Буковинський державний медичний університет»
  • T. M. Danylyshyn ВДНЗ України «Буковинський державний медичний університет»
  • M. P. Antofiychuk ВДНЗ України «Буковинський державний медичний університет»
  • O. V. Kaushanska ВДНЗ України «Буковинський державний медичний університет»

DOI:

https://doi.org/10.11603/1811-2471.2018.v0.i1.8591

Keywords:

non-alcoholic liver disease, diabetes mellitus, dislipidemia, plasmapheresis.

Abstract

The article describes the clinical case of non-alcoholic fatty liver disease with concomitant diabetes mellitus and their treatment with the help of plasmapheresis. Changes in the parameters of blood analysis, lipidogram and hemogram are presented. It is concluded that this method can be considered an effective component of pathogenetic therapy for such patients.

References

Bodnar P.M., Mykhal'chyshyn H.P., Kobylyak N.M. Nealkohol'na zhyrova khvoroba pechinky u khvorykh na tsukrovyy diabet typu 2: patohenez, diahnostyka ta likuvannya. Endokrynolohiya. 2012; 1:17 — 8.

Kobylyak N.M., Bodnar P.M., Mykhal'chyshyn H.P., Dynnyk O.B. Diahnostychna efektyvnist' hepatorenal'noho indeksu u khvorykh na tsukrovyy diabet typu 2 z nealkohol'nym steatohepatozom. Ukrayins'kyy medychnyy chasopys. 2012; 6:92. — 4.

Lutay M.Y. Evropeyskye rekomendatsyy po lechenyyu dyslypydemyy (2016): prezhnye tsely – novыe puty. Materyalы Kh ezhehodnoho zasedanyya Ukraynskoho obshchestva ateroskleroza «Mnohofaktornaya profilaktyka ateroskleroza y eho oslozhnenyy». Zdorov"ya Ukrayiny. 2017; 1 – 2.

DiNicolantonio J.J., Subramonian A.M., O’Keefe J.H. Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis. Open Heart.2017; 4:2 – e000631.

Tkach S.M., Cheverda T.L. Nealkohol'na zhyrova khvoroba pechinky: poshyrenist', pryrodnyy perebih, suchasni pidkhody do diahnostyky ta likuvannya. Klinichna endokrynolohiya ta endokrynna khirurhiya. 2016; 1:53 – 9.

Kurhan M. H., Prokopchuk S. Yu., Kurhan D. M., Kurhan H. M., Prymak S. V., Novak V. L. Sposib dyskretnoho likuval'noho plazmafarezu. Patent # 73461 opubl. 15.07.2005

Skrypnyk N.V. Patohenetychne obgruntuvannya hepatoprotektornoyi terapiyi u khvorykh na tsukrovyy diabet. Mizhnarodnyy endokrynolohichnyy zhurnal. 2014;6:62 — 6.

Diehl A.M., Day C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. N. Engl. J. Med., 2017;377:21 – 10.

Published

2018-05-22

How to Cite

Khukhlina, O. S., Danylyshyn, T. M., Antofiychuk, M. P., & Kaushanska, O. V. (2018). CORRECTION OF LIPID EXCHANGE DEVIATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASES WITH CONCOMINANT DIABETES MELLITUS. Achievements of Clinical and Experimental Medicine, (1). https://doi.org/10.11603/1811-2471.2018.v0.i1.8591

Issue

Section

Оригінальні дослідження